Replies to post #6266 on Halozyme Therapeutics Inc (HALO)

[maumar]

I hope you're right but I'm afraid Halo will need to exceed estimates every quarter, sign new deals and make very strong progress in their phase 3 trials for the stock to get to $70 by EOY 2021.

If they sell the company in the next six months, $70 seems like a pretty fair price.